AstraZeneca Fourth quarter and full year results 2011
Thursday, 2 February 2012
AstraZeneca R&D President Martin Mackay discusses discusses R&D performance and productivity during company’s 2011 full-year and fourth quarter results.
Additional management interviews are available alongside our financial results announcement: